Platform Rebrand of Researgency.ai; First Purpose-Built AI Agent for Biotech Expected to Ship Within Two WeeksARLINGTON, Mass ...
Kala Bio Inc. KALA shares are up during Wednesday’s premarket session as the company is preparing to ship its first commercial AI product in approximately 14 days. Kala Bio Ready to Ship First AI ...
KALA BIO (KALA) stock soared 70% pre-market after revealing plans to launch its first commercial AI agent in 14 days through ...
Kala Bio (KALA) stock jumps after licensing Younet AI’s Researgency LLM platform to build AI infrastructure for biopharma.
Company launches initiative to become a dedicated AI infrastructure partner for the biotechnology industry — to deploy secure, on-premises AI ...
On March 3, 2026, KALA BIO entered into a 12‑month Platform Development and Exclusive License Agreement with Younet AI, securing a worldwide exclusive license to the proprietary Researgency biomedical ...
ARLINGTON, Mass., May 23, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of ...
Shares of Kala Pharmaceuticals surged Wednesday after the small biotechnology company announced a drug candidate for a rare eye disease. The Food and Drug Administration has accepted Kala's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results